Discover
VTGN
VistaGen Therapeutics, Inc.
0.27
1 x 0.25
50 x 0.29
bid
ask
+
0.01
2.01%
1 @ 04:00 PM
0.27 +0.00 (0.00%)
| Ytd | -59.23% | |
| 1y | -90.52% |
0.25
day range
0.28
0.20
52 week range
5.14
| Open | 0.27 | Prev Close | 0.26 | Low | 0.25 | High | 0.28 | Mkt Cap | 11.94M |
| Vol | 0.00 | Avg Vol | 4.15M | EPS | -1.83 | P/E | -0.15 | Forward P/E | -1.49 |
| Beta | 0.41 | Short Ratio | 1.69 | Inst. Own | 53.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.40 | 200-d Avg | 1.27 | 1yr Est | 13.00 |
| Income Statement | |||
| Total Revenue | 465.00K | ||
| Revenues (USD) | 465.00K | ||
| Gross Profit | 465.00K | ||
| Operating Expenses | 17.18M | ||
| Research and Development Expense | 13.06M | ||
| Selling, General and Administrative Expense | 4.12M | ||
| Operating Income | -16.72M | ||
| Income Tax Expense | 7.00K | ||
| Net Income | -16.27M | ||
| Net Income Common Stock | -16.27M | ||
| Net Income Common Stock (USD) | -16.27M | ||
| Consolidated Income | -16.27M | ||
| Earnings per Basic Share | -0.37 | ||
| Earnings per Basic Share (USD) | -0.37 | ||
| Earnings per Diluted Share | -0.37 | ||
| Earning Before Interest & Taxes (EBIT) | -16.27M | ||
| Earning Before Interest & Taxes (USD) | -16.27M | ||
| Weighted Average Shares | 42.33M | ||
| Weighted Average Shares Diluted | 42.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.79M | ||
| Cash and Equivalents (USD) | 30.79M | ||
| Investments | 14.61M | ||
| Investments Current | 14.61M | ||
| Current Assets | 46.94M | ||
| Property, Plant & Equipment Net | 1.23M | ||
| Total Assets | 48.56M | ||
| Debt Current | 795.00K | ||
| Total Debt | 1.04M | ||
| Current Liabilities | 12.80M | ||
| Debt Non-Current | 249.00K | ||
| Total Liabilities | 13.04M | ||
| Accumulated Retained Earnings (Deficit) | -477.32M | ||
| Accumulated Other Comprehensive Income | -2.00K | ||
| Shareholders Equity | 35.52M | ||
| Shareholders Equity (USD) | 35.52M | ||
| Assets Non-Current | 1.62M | ||
| Total Debt (USD) | 1.04M | ||
| Deferred Revenue | 1.71M | ||
| Liabilities Non-Current | 249.00K | ||
| Trade and Non-Trade Payables | 1.54M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 190.00K | ||
| Net Cash Flow from Financing | -283.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.58M | ||
| Issuance (Repayment) of Debt Securities | -283.00K | ||
| Net Cash Flow from Investing | -99.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -99.00K | ||
| Net Cash Flow from Operations | -16.20M | ||
| Share Based Compensation | 889.00K | ||